Are you Dr. Sangha?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 5 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4501 X St
Suite 3019
Sacramento, CA 95817Phone+1 916-734-0517Fax+1 916-734-7946- Is this information wrong?
Summary
- Dr. Randeep Sangha, MD is an oncologist in Sacramento, California. He is currently licensed to practice medicine in California.
Education & Training
University of AlbertaClass of 2002
Certifications & Licensure
CA State Medical License 2007 - 2025
Publications & Presentations
PubMed
- 128 citationsFirst-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 TrialLuis Paz-Ares, Suresh S. Ramalingam, Tudor-Eliade Ciuleanu, Jong Seok Lee, László Urbán, Reyes Bernabe Caro, Keunchil Park, Hiroshi Sakai, Yuichiro Ohe, Makoto Nishio,...> ;Journal of Thoracic Oncology. 2021 Oct 12
- 9 citationsRetrospective Real-World Outcomes for Patients With ALK-Rearranged Lung Cancer Receiving ALK Receptor Tyrosine Kinase Inhibitors.A. Gibson, Adrian Box, Michelle Dean, A. Elegbede, Desiree Hao, Randeep Sangha, D. Gwyn Bebb> ;JTO Clinical and Research Reports. 2021 Apr 1
- A reply to "Correspondence Re: Development, validation and results from the impact of treatment evolution in non-small cell lung cancer (iTEN) model".D. Moldaver, M. Hurry, William K. Evans, Parneet K. Cheema, Randeep Sangha, Ronald Burkes, Barbara Melosky, D. Tran, Darryl Boehm, Jaya Venkatesh, Susan Walisser, Erik...> ;Lung Cancer. 2021 Jan 1
- Join now to see all
Press Mentions
Pacylex Presents Evidence Supporting Advancement of PCLX-001 for Treatment of AML at AACR 2022April 8th, 2022- Pacylex Pharmaceuticals Announces Publication in Current Oncology of First Clinical Experience with an N-myristoyltransferase (NMT) Inhibitor in a Patient with Diffuse Large B-cell Lymphoma (DLBCL)March 14th, 2022
- Pacylex Presented Initial Clinical Experience with PCLX-001 in Patients at ASH 2021December 13th, 2021
- Join now to see all
